CATest

CAT for Healthcare Professionals

click here to print this page

How do I interpret CAT scores and act on them?

Both the overall score (in the range of 0–40) and the scores for the individual items can provide useful information1.

OVERALL SCORE

A CAT score needs to be considered in the context of other information such as FEV1, exacerbation frequency, and presence of co-morbidities. Patients with more severe airways obstruction and more frequent exacerbations would be expected to have higher CAT scores than patients with milder disease.

Experts involved developing the CAT suggest that a change of 2 or more units may indicate a clinically significant change in health status1. However, more clinical investigations are needed to confirm this. Following an exacerbation CAT scores may improve by an average of 5 units over 2-3 months, compared to their score during the exacerbation1,2.

CAT
score

 Impact level
Possible management considerations


<10


Low


  • Smoking cessation
  • Annual influenza vaccination
  • Reduce exposure to exacerbation risk factors
  • Therapy as warranted by further clinical assessment.


10–20


Medium


Patient has room for improvement.
In addition to the guidance provided for patients with low impact CAT scores, you could consider:

  • Reviewing maintenance therapy – is it optimal?
  • Referral for pulmonary rehabilitation
  • Ensuring best approaches to minimising and managing exacerbations
  • Reviewing aggravating factors – is the patient still smoking? 


21–30


High


Patient has significant room for improvement
In addition to the guidance for patients with low and medium impact CAT scores, you could consider:

  • Referral to specialist care (if you are in general practice)
  • Additional pharmacological treatments


>30


Very High

 

SCORES FOR INDIVIDUAL ITEMS

The scores for individual items can be used to guide where within the spectrum of possible management decisions you should focus your effort to optimise care.

Frequently Asked Questions about CAT scores1

Below is a list of questions you might have about the CAT. Click on a question to learn the answer.

Back to top


References

  1. The COPD Assessment Test healthcare professional user guide: expert guidance on frequently asked questions. Jones PW, Jenkins C, Bauerle O (on behalf of the CAT Development Steering Group).
  2. Jones et al. European Respiratory Journal 2009; 34: 648-654.

Page Last Updated: April 25, 2012

COPD Assessment Test and CAT logo is a trade mark of the GlaxoSmithKline group of companies.
©2009 GlaxoSmithKilne group of companies. All rights reserved.

Click Here to take the CATest
 
To print a paper version of CAT, click here. You will need Adobe Acrobat to read this file. Click here to download Adobe Acrobat.
 
If you are a healthcare professional, this guide will show you how to use the CAT in the best way.
GlaxoSmithKline

COPD Assessment Test and CAT logo is a trade mark of the GlaxoSmithKline group of companies.
©2009 GlaxoSmithKilne group of companies. All rights reserved.
Contact us
This website is intended for residents of the UK only.
Please read the legal notices and privacy notices.
Specific medical advice should always be sought from a qualified medical practitioner.
The development of the COPD Assessment Test was funded by GlaxoSmithKline.
GlaxoSmithKline UK Limited. Registered in England. Company No. 4310159.
Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.
Code number: UK/RESP/0014/12 April 2012.